PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [ ¹⁸ F]SiTATE - first clinical experiences.

Autor: Kunte SC; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Wenter V; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Toms J; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Lindner S; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Unterrainer M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; DIE RADIOLOGIE, Munich, Germany., Eilsberger F; Department of Nuclear Medicine, School of Medicine, Philipps University Marburg, Marburg, Germany., Jurkschat K; Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund, Dortmund, Germany., Wängler C; Biomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.; Research Campus M²OLIE, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany., Wängler B; Research Campus M²OLIE, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.; Medical Faculty Mannheim of Heidelberg University, Molecular Imaging and Radiochemistry, Clinic of Radiology and Nuclear Medicine, Mannheim, Germany., Schirrmacher R; Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, AB, Canada., Tiling MW; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Sheikh GT; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Mehrens D; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a Partnership Between DKFZ and Ludwig-Maximilians-Universität München (LMU), Munich, Germany., Rübenthaler J; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Auernhammer CJ; Department of Internal Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Spitzweg C; Department of Internal Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Unterrainer LM; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.; Bayerisches Zentrum für Krebsforschung (BZKF), Partner Site Munich, Munich, Germany., Holzgreve A; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Adrien.Holzgreve@med.lmu.de.; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Adrien.Holzgreve@med.lmu.de.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ultrasound-Assisted Solid-Phase Affibody Synthesis Using Z EGFR:1907 as an Example-Superior to the Conventional Protocol?

Autor: Prochiner M; Biomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.; Research Campus M²OLIE, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany., Judmann B; Biomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.; Research Campus M²OLIE, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany., Ruder A; Biomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.; Research Campus M²OLIE, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany., Wängler B; Research Campus M²OLIE, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.; Molecular Imaging and Radiochemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany., Schirrmacher R; Division of Oncological Imaging, Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada., Wängler C; Biomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.; Research Campus M²OLIE, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.

Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Sep 27; Vol. 17 (10). Date of Electronic Publication: 2024 Sep 27.

Comparing quantitative image parameters between animal and clinical CT-scanners: a translational phantom study analysis.

Autor: Vellala A; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Mogler C; Department of Pathology, Technical University of Munich, Munich, Germany., Haag F; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Tollens F; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Rudolf H; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Pietsch F; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Wängler C; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Wängler B; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Schoenberg SO; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Froelich MF; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Hertel A; Department of Radiology and Nuclear medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2024 Jun 05; Vol. 11, pp. 1407235. Date of Electronic Publication: 2024 Jun 05 (Print Publication: 2024).

Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update.

Autor: Iliev P; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada., Jaworski C; Department of Oncology, University of Alberta, Edmonton, Canada., Wängler C; Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany., Wängler B; Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany., Page BDG; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada., Schirrmacher R; Department of Oncology, University of Alberta, Edmonton, Canada., Bailey JJ; Life Sciences Division, TRIUMF, Vancouver, Canada.

Publikováno v: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Apr; Vol. 34 (4), pp. 231-244. Date of Electronic Publication: 2024 May 30.